Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroectodermal Tumors × Oncolytic Virotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms, Neuroepithelial 1 Neoplasms, Nerve Tissue 1 Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Disease 1 Brain Neoplasms 1

Interventions

pembrolizumab 1 cixutumumab 1 Vorinostat 1 Temozolomide 1 Sunitinib 1 Oncolytic Virotherapy 1 Erlotinib Hydrochloride 1 Antibodies, Monoclonal 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02798406 2021-07-15

CAPTIVE

DNAtrix, Inc.

Phase 2 Completed

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡